ZenMode333 @ZenModeOfficial - Twitter Profile

Caffeine has been the most studied stimulant in history. Billions of people use it daily. And we're only now running trials on the primary compound it converts into. That tells you something about how we approach nutrition science we study the source, not the mechanism. Paraxanthine research is still in early stages. More large-scale human trials are needed. But the underlying biology is well-mapped and the early data is directionally consistent. I'll be following where this goes. What part of this was most surprising to you?

ZenModeOfficial's tweet photo. Caffeine has been the most studied stimulant in history. Billions of people use it daily. And we're only now running trials on the primary compound it converts into.

That tells you something about how we approach nutrition science we study the source, not the mechanism.

Paraxanthine research is still in early stages. More large-scale human trials are needed. But the underlying biology is well-mapped and the early data is directionally consistent.

I'll be following where this goes. What part of this was most surprising to you?

0

12

ZenMode333

@ZenModeOfficial

about 2 months ago

Most people think caffeine is the active ingredient in coffee. It's not. Caffeine is basically the delivery vehicle. Your liver metabolizes it into something else entirely — and THAT compound is what crosses the blood-brain barrier and does the actual work. That compound is paraxanthine. And almost nobody is talking about it.

ZenModeOfficial's tweet photo. Most people think caffeine is the active ingredient in coffee.

It's not. Caffeine is basically the delivery vehicle. Your liver metabolizes it into something else entirely — and THAT compound is what crosses the blood-brain barrier and does the actual work.

That compound is paraxanthine. And almost nobody is talking about it.

1

0

22

ZenMode333

@ZenModeOfficial

about 2 months ago

One thing most people skip past in the research: the safety threshold data. NOAEL — the dose level where no adverse effects are observed — is 185 mg/kg for paraxanthine vs. 150 mg/kg for caffeine. Higher ceiling. And preclinical studies found zero mortality in the paraxanthine group at doses that produced fatalities in the caffeine group. That's not a minor footnote. If you're going to compare two stimulants, the safety floor matters as much as the performance ceiling. The cognitive gap in studies is real. But the safety data is what makes researchers take this seriously.